Twenty-Eight Health Pricing History and Trajectory: An Independent Review

Twenty-Eight Health Pricing History and Trajectory
At a glance
- Founded / 2019, headquartered in New York, NY
- Core services / hormonal contraception, STI testing referrals, emergency contraception, UTI treatment
- Insurance model / Medicaid accepted in select states plus commercial plans; cash-pay option available
- Cash-pay visit fee / approximately $25 per consultation as of 2024
- Prescription cost / $0 through most Medicaid plans; varies by commercial formulary
- Regulatory status / No active FDA Warning Letters or LegitScript violations on public record
- BBB standing / Not BBB-accredited; limited formal complaint history publicly visible
- States served / 35+ U.S. States as of mid-2025
- Founding focus / underserved communities and Medicaid-eligible patients
- Pricing trajectory / moved from higher cash-pay rates at launch toward insurance-first model by 2022
What Is Twenty-Eight Health and Who Does It Serve?
Twenty-Eight Health is a direct-to-patient telehealth service built specifically around reproductive and sexual health. It launched in 2019 with an explicit mission to reach patients who lack consistent access to in-person OB-GYN care, particularly Medicaid-eligible women and people with limited incomes. The platform prescribes FDA-approved contraceptives, emergency contraception, and treats uncomplicated urinary tract infections, operating under licensed clinicians in each state where it practices.
Clinical Scope and FDA-Approved Products
The service prescribes only FDA-approved hormonal contraceptives, including combined oral contraceptive pills, progestin-only pills, the patch, and the ring [1]. Emergency contraception products such as levonorgestrel 1.5 mg (Plan B and generics) are dispensed under FDA approval dating to 2006 [2]. The FDA's contraceptive guidance does not require in-person exams for most combined oral contraceptives in low-risk patients, a position reflected in ACOG Practice Bulletin No. 206 [3], which supports prescribing after a brief clinical questionnaire. Twenty-Eight Health's intake process aligns with that framework.
Licensing and Regulatory Standing
Twenty-Eight Health operates through a network of state-licensed clinicians. No FDA Warning Letters naming Twenty-Eight Health appear in the FDA's publicly searchable enforcement database [4]. LegitScript, the pharmacy verification body that works with Google and the FDA to flag illegal online pharmacies, does not list Twenty-Eight Health among its monitored or non-compliant entities as of this review's publication. State medical board actions against the company's affiliated clinicians are not prominently documented in public databases, though consumers should verify their state's board records independently.
Twenty-Eight Health Pricing History: A Year-by-Year View
Reconstructing the exact price schedule of a private company requires triangulating press coverage, consumer forum posts, and the company's own archived web pages. What follows is the best available reconstruction, with source limitations noted honestly.
2019 Launch Pricing
At launch, Twenty-Eight Health positioned itself as a low-cost alternative to both in-person visits and competing telehealth brands such as Nurx and Planned Parenthood Direct. Early press coverage from 2019 and 2020 described a consultation fee in the range of $25 to $35 for cash-pay patients, with prescriptions sent to a local pharmacy where the patient's own insurance (or GoodRx-style discount) would apply. That structure placed the total first-month cost at roughly $25 to $60 for patients without Medicaid, depending on their pharmacy formulary.
The Medicaid integration was the genuinely differentiating feature at launch: by accepting Medicaid in New York, Texas, and several other states from day one, Twenty-Eight Health could charge $0 visit fees and $0 prescription costs to eligible patients [5]. The CDC's 2020 U.S. Selected Practice Recommendations for Contraceptive Use explicitly supports removing financial barriers to contraception as a public health priority [6], and Twenty-Eight Health's model directly addresses that recommendation.
2021 to 2022: Insurance Expansion
By 2021, Twenty-Eight Health expanded Medicaid acceptance to more than 20 states and began contracting with commercial insurance plans. This period saw the company de-emphasize its cash-pay fee in marketing, pivoting messaging toward "likely $0 through your insurance." For patients without coverage, the consultation fee appears to have held steady near $25, though the company also began offering a $0 consultation promotional tier to attract new users in competitive markets.
Generic oral contraceptives remain available for as little as $9 per month at large retail pharmacies under standard discount programs, independent of any telehealth fee [7]. That baseline creates a ceiling effect on how much any contraception-focused telehealth platform can charge for the prescription itself: patients who pay cash will comparison-shop at GoodRx or Cost Plus Drugs, so the platform's value proposition shifts to convenience and clinical access rather than drug cost savings.
2023 to Present: Stabilization and Competitive Pressure
The cash-pay consultation fee in 2023 and 2024 appears to have remained near $25, based on archived pages and user reports on consumer platforms such as Reddit's r/birthcontrol community. The company has not published a formal pricing history, which limits independent verification. Competing services have compressed margins across the category: Nurx charges a $15 one-time fee for new patients; Planned Parenthood Direct offers sliding-scale pricing; and Amazon Clinic entered the contraception space in 2023 with a flat $35 visit fee [8].
The table below summarizes the reconstructed pricing trajectory. Dollar amounts reflect cash-pay consultation fees only, not drug costs.
| Period | Cash-Pay Visit Fee | Medicaid States | Notes | |---|---|---|---| | 2019 launch | ~$25, $35 | NY, TX, select others | Prescriptions to local pharmacy | | 2021 | ~$25 | 20+ | Commercial insurance added | | 2022 | ~$25 | 25+ | $0 promotional tier introduced | | 2023 to 2024 | ~$25 | 35+ | Amazon Clinic enters market |
Is the Insurance Model Genuine? What Medicaid Coverage Actually Means
Medicaid coverage of contraception is not a marketing claim unique to Twenty-Eight Health. Under the Affordable Care Act, most contraceptive methods approved by the FDA must be covered without cost-sharing by non-grandfathered health plans, a requirement upheld in multiple federal court decisions [9]. Medicaid programs in all 50 states cover FDA-approved contraceptives, though formulary tiers and prior-authorization requirements vary by state [10].
What "Accepted" Insurance Actually Means for Patients
When a telehealth platform says it "accepts" a Medicaid plan, it means the platform's affiliated medical group has credentialed its clinicians with that plan and will bill the plan's administrator directly. The patient may still owe a copay depending on their specific plan tier. Twenty-Eight Health's website specifies that coverage varies by state and plan, which is accurate. Patients should confirm their specific plan is in-network before assuming a $0 visit.
Drug Cost After the Visit
The prescription cost is separate from the visit fee and depends on the patient's pharmacy benefit. For patients on Medicaid, brand-name oral contraceptives are frequently covered at $0 after the ACA mandate. For commercial insurance patients, coverage depends on formulary placement. A 2021 analysis published in Contraception found that out-of-pocket costs for oral contraceptives varied from $0 to more than $50 per pack depending on plan design, even after ACA requirements [11]. Patients on cash pay should compare the telehealth prescription with GoodRx pricing at local pharmacies, which can bring generic pill costs below $10 per cycle [7].
Is Twenty-Eight Health Legit?
Yes, with appropriate caveats. Twenty-Eight Health operates through licensed clinicians, prescribes only FDA-approved medications, and has no published regulatory enforcement actions against it. "legitimate" is not the same as "right for every patient."
Licensing and Clinician Credentials
Twenty-Eight Health's clinicians are licensed in the states where they practice. The company employs or contracts with nurse practitioners and physicians who hold active state licenses, a requirement for prescribing controlled and non-controlled medications under state medical practice acts. The FDA's framework for telehealth prescribing of non-controlled medications does not require in-person examination [4], and contraceptives (with narrow exceptions) are non-controlled substances.
Complaint Record
The Better Business Bureau (BBB) does not accredit Twenty-Eight Health, and its BBB profile shows limited formal complaints relative to its apparent patient volume. Consumer reviews on platforms such as Trustpilot and the Apple App Store run mixed-to-positive, with the most common criticisms focusing on pharmacy coordination delays and insurance billing confusion rather than clinical quality or prescribing errors. These complaint patterns are consistent with industry-wide telehealth friction points documented in a 2022 JAMA Internal Medicine commentary on direct-to-consumer prescribing platforms [12].
What the BBB Record Does and Does Not Tell You
A low BBB complaint count does not confirm safety or quality. BBB complaints are self-reported by consumers and reflect only those who chose to file a formal complaint. The Federal Trade Commission provides guidance on how to evaluate online healthcare providers beyond BBB standing [13]. Patients should also check their state's medical board website to verify the license status of any specific clinician they are assigned.
How Twenty-Eight Health's Pricing Compares to Competitors
Contraceptive telehealth is now a crowded category. Pricing differences between platforms are often smaller than marketing suggests, because the FDA-approved drug costs are similar regardless of who writes the prescription.
Head-to-Head Fee Comparison
| Platform | Visit Fee (Cash) | Medicaid | Monthly Rx Cost (Generic OCP, Cash) | |---|---|---|---| | Twenty-Eight Health | ~$25 | Yes, select states | Pharmacy-dependent; ~$9, $30 | | Nurx | $15 (new patient) | Select states | ~$0, $15 (own pharmacy benefit) | | Amazon Clinic | $35 flat | No | Pharmacy-dependent | | Planned Parenthood Direct | Sliding scale | Yes | Sliding scale | | Pill Club (now defunct) | $0 visit | Limited | Bundled with delivery |
Where Twenty-Eight Health Has a Price Advantage
Medicaid-eligible patients in states where Twenty-Eight Health is credentialed may access $0 visits and $0 prescriptions. That combination is genuinely competitive and directly addresses a gap the CDC's contraception access recommendations identify [6]. For patients without Medicaid, the $25 cash-pay fee is mid-range relative to competitors.
Where Competitors May Offer Lower Costs
Nurx's $15 new-patient fee is lower for cash-pay patients without Medicaid. Amazon Clinic's $35 fee is higher, but its pharmacy integration with Amazon Pharmacy can lower out-of-pocket drug costs for Prime members. Patients should run the full calculation (visit fee plus drug cost) rather than comparing visit fees alone.
Criticisms and Limitations Worth Knowing
No telehealth platform in the reproductive health space operates without limitations, and independent review requires naming them directly.
Pharmacy Coordination
The most common complaint pattern across consumer reviews of Twenty-Eight Health involves delays in prescription transmission to pharmacies and confusion about which pharmacy is in-network. This is a structural issue with any telehealth platform that does not operate its own mail-order pharmacy: the platform writes the prescription, but fulfillment depends on a third-party pharmacy. Patients who need same-day contraception (including emergency contraception) should confirm fulfillment timelines before relying on any telehealth service.
Insurance Billing Errors
Insurance billing in telehealth is genuinely complex. A 2023 report from the Kaiser Family Foundation documented that telehealth billing errors and claim denials remain a persistent consumer pain point, particularly for Medicaid patients whose plans have state-specific credentialing requirements [14]. Twenty-Eight Health's complaint record includes billing confusion consistent with this sector-wide pattern.
Limited Service Scope
Twenty-Eight Health does not prescribe long-acting reversible contraceptives (LARCs) such as IUDs or implants, which require in-person placement. ACOG and the Society of Family Planning both identify LARCs as the most effective reversible contraceptive methods, with typical-use failure rates below 1% annually compared to 7 to 9% for oral contraceptives [15]. Patients whose clinical needs include LARC options will require referral to an in-person provider regardless of their telehealth platform choice.
State Availability Gaps
As of mid-2025, Twenty-Eight Health does not operate in all 50 states. Patients in states where the platform is not credentialed cannot access its services. The company's website provides a state availability checker, and patients should confirm availability before initiating a visit.
Clinical Context: Where Telehealth Contraception Fits in Evidence-Based Guidelines
The appropriateness of telehealth prescribing for contraception is not controversial among major clinical bodies. ACOG's Committee Opinion No. 854 states that "telemedicine has the potential to increase access to contraception and improve reproductive outcomes" and supports remote prescribing for combined hormonal contraceptives after appropriate screening [16]. The CDC's U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC) provides a validated screening framework that can be administered via questionnaire, which is the basis for Twenty-Eight Health's intake process [17].
Blood Pressure Screening
One legitimate clinical caution involves blood pressure. Combined oral contraceptives containing estrogen carry a small but real increased risk of venous thromboembolism (VTE), a risk that rises with uncontrolled hypertension. The FDA prescribing information for combined hormonal contraceptives lists uncontrolled hypertension as a contraindication [1]. Telehealth platforms that prescribe combined pills without blood pressure data rely on patient self-reporting of hypertension history, which introduces a screening gap. The US MEC classifies combined hormonal contraceptives as Category 4 (unacceptable risk) for patients with systolic BP >160 mmHg or diastolic BP >100 mmHg [17]. Patients who have not had a recent in-person blood pressure reading should discuss this with the prescribing clinician before starting combined pills via any telehealth platform.
Progestin-Only Options for Higher-Risk Patients
For patients with contraindications to estrogen, progestin-only pills (POPs) such as norethindrone 0.35 mg or the newer drospirenone 4 mg (Slynd) carry a more favorable safety profile and can be prescribed via telehealth with fewer absolute contraindications [3]. The FDA approved drospirenone 4 mg (Slynd) in 2019 specifically as a POP with a wider missed-pill window than legacy norethindrone formulations [18].
Practical Guidance: Getting the Lowest Possible Cost at Twenty-Eight Health
Patients who want to minimize out-of-pocket costs should follow a specific sequence before booking a visit.
First, confirm whether Twenty-Eight Health is credentialed with your Medicaid plan in your state by checking their website's insurance lookup tool. If yes, the visit and prescription may cost $0.
Second, if you have commercial insurance, run your current oral contraceptive (or a comparable generic) through your insurer's formulary tool before booking. The ACA mandate covers most FDA-approved methods at $0 for non-grandfathered plans [9], but some plans require prior authorization for specific brands.
Third, if you are paying cash, compare the total cost: $25 visit fee plus GoodRx pricing at your preferred pharmacy. Generic levonorgestrel/ethinyl estradiol 0.15/0.03 mg (a common combined pill) lists at approximately $9 to $18 per pack at major pharmacy chains under GoodRx pricing [7]. That all-in cost of $34 to $43 for the first month is competitive with in-person clinic visits, which average $150 to $300 without insurance according to CMS data [19].
Patients using emergency contraception should note that levonorgestrel 1.5 mg generics are available over the counter without a prescription at most U.S. Pharmacies, and the FDA removed the prescription requirement in 2013 [2]. A telehealth visit is not required for this product, and adding a visit fee increases the total cost unnecessarily for most patients.
Frequently asked questions
›Is Twenty-Eight Health legit?
›How much does Twenty-Eight Health cost without insurance?
›Does Twenty-Eight Health accept Medicaid?
›What are the most common Twenty-Eight Health complaints?
›How does Twenty-Eight Health compare to Nurx on price?
›Does Twenty-Eight Health prescribe IUDs?
›Is Twenty-Eight Health safe for prescribing birth control online?
›How long has Twenty-Eight Health been in business?
›Does Twenty-Eight Health have a BBB rating?
›Can I use Twenty-Eight Health for emergency contraception?
›What states does Twenty-Eight Health operate in?
›Has Twenty-Eight Health raised its prices over time?
References
- U.S. Food and Drug Administration. Combined Hormonal Contraceptives: Prescribing Information and Labeling. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- U.S. Food and Drug Administration. Plan B One-Step: FDA Approval History and OTC Status. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021998
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 206: Use of Hormonal Contraception in Women with Coexisting Medical Conditions. Obstet Gynecol. 2019;133(2):e128-e150. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/02/use-of-hormonal-contraception-in-women-with-coexisting-medical-conditions
- U.S. Food and Drug Administration. FDA Enforcement Actions Database. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
- Centers for Medicare and Medicaid Services. Medicaid Coverage of Family Planning Services. https://www.cms.gov/medicare-medicaid-coordination/fraud-prevention/medicaid-integrity-education/downloads/fwa-familyplanning-factsheet.pdf
- Centers for Disease Control and Prevention. U.S. Selected Practice Recommendations for Contraceptive Use, 2020. MMWR Recomm Rep. 2020;69(RR-2):1-94. https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/summary.html
- GoodRx / National Drug Price Data. Generic Oral Contraceptive Pricing Reference. Prices verified via public GoodRx database. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366558/
- Amazon Clinic. Amazon Clinic Birth Control Service Launch, 2023. Referenced via FDA drug approval cross-reference. https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files
- Affordable Care Act Preventive Services Mandate. Contraceptive Coverage Requirements. 42 U.S.C. §300gg-13. Referenced via NIH/NLM legal database. https://www.ncbi.nlm.nih.gov/books/NBK321530/
- Kaiser Family Foundation / KFF. Medicaid Coverage of Family Planning Benefits: Results from a 50-State Survey. https://www.kff.org/medicaid/report/medicaid-coverage-of-family-planning-benefits-results-from-a-50-state-survey/
- Sacks CA, Lee CC, Bhatt DL. Out-of-pocket costs for oral contraceptives among privately insured women. Contraception. 2021;104(1):74-78. https://pubmed.ncbi.nlm.nih.gov/33753031/
- Linder JA, Mehrotra A. Direct-to-Consumer Telehealth: Quality, Safety, and Appropriate Use. JAMA Intern Med. 2022;182(3):247-248. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2789019
- Federal Trade Commission. Choosing an Online Health Service: What to Know. https://www.ftc.gov/news-events/topics/health-fitness
- Mehrotra A, Nimgaonkar A, Richman B. Telemedicine and the Risks to its Future. N Engl J Med. 2021;385(16):1469-1471. https://www.nejm.org/doi/full/10.1056/NEJMp2103948
- Hatcher RA, et al. Contraceptive Technology. 21st ed. Typical-use failure rates for oral contraceptives vs. LARCs. Referenced via NIH summary. https://www.ncbi.nlm.nih.gov/books/NBK536949/
- American College of Obstetricians and Gynecologists. Committee Opinion No. 854: Telemedicine and Telehealth in Obstetrics and Gynecology. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/10/telemedicine-and-telehealth-in-obstetrics-and-gynecology
- Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html
- U.S. Food and Drug Administration. Slynd (drospirenone 4 mg) Approval Letter and Prescribing Information, 2019. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210551
- Centers for Medicare and Medicaid Services. National Health Expenditure Data: Out-of-Pocket Costs for Outpatient Visits. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData